• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对组织限制性抗原亲和力低的T细胞通常会逃避中枢和外周耐受并引发自身免疫。

T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.

作者信息

Zehn Dietmar, Bevan Michael J

机构信息

Department of Immunology, Howard Hughes Medical Institute, University of Washington, Seattle, Washington 98195, USA.

出版信息

Immunity. 2006 Aug;25(2):261-70. doi: 10.1016/j.immuni.2006.06.009. Epub 2006 Aug 3.

DOI:10.1016/j.immuni.2006.06.009
PMID:16879996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2774714/
Abstract

T cells causing autoimmunity must escape tolerance. We observed that CD8(+) T cells with high avidity for an antigen expressed in the pancreas, kidney, and thymic medulla were efficiently removed from a polyclonal repertoire by central and peripheral tolerance mechanisms. However, both mechanisms spared low-avidity T cells from elimination. Neither the introduction of activated, self-antigen-specific CD4(+) helper T cells nor a global inflammatory stimulus were sufficient to activate the low-avidity CD8(+) T cells and did not break tolerance. In contrast, challenge with a recombinant bacterium expressing the self antigen primed the low-avidity T cells, and the animals rapidly developed autoimmune diabetes. We suggest that whereas thymic and peripheral tolerance mechanisms remove cells that can be primed by endogenous amounts of self antigen, they do not guard against tissue destruction by low-avidity effector T cells, which have been primed by higher amounts of self antigen or by crossreactive antigens.

摘要

引发自身免疫的T细胞必须逃避免疫耐受。我们观察到,对胰腺、肾脏和胸腺髓质中表达的抗原具有高亲和力的CD8(+) T细胞通过中枢和外周耐受机制从多克隆库中被有效清除。然而,这两种机制都使低亲和力T细胞免于被清除。无论是引入活化的、自身抗原特异性的CD4(+)辅助性T细胞,还是全身性炎症刺激,都不足以激活低亲和力CD8(+) T细胞,也无法打破免疫耐受。相反,用表达自身抗原的重组细菌进行攻击可使低亲和力T细胞致敏,动物会迅速发展为自身免疫性糖尿病。我们认为,虽然胸腺和外周耐受机制会清除那些可被内源性自身抗原激活的细胞,但它们无法防止低亲和力效应T细胞对组织的破坏,这些低亲和力效应T细胞已被大量自身抗原或交叉反应性抗原激活。

相似文献

1
T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.对组织限制性抗原亲和力低的T细胞通常会逃避中枢和外周耐受并引发自身免疫。
Immunity. 2006 Aug;25(2):261-70. doi: 10.1016/j.immuni.2006.06.009. Epub 2006 Aug 3.
2
T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.转基因小鼠中T细胞和B细胞的耐受性以及对病毒抗原的反应:对自身免疫性疾病与免疫病理疾病发病机制的启示
Immunol Rev. 1991 Aug;122:133-71. doi: 10.1111/j.1600-065x.1991.tb00601.x.
3
[Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].[病毒抗原诱导的自身免疫:1型糖尿病的动物模型]
Verh Dtsch Ges Pathol. 1994;78:177-9.
4
Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo.免疫调节性树突状细胞需要自体血清来规避体内的非特异性免疫抑制活性。
Blood. 2005 Dec 15;106(13):4225-33. doi: 10.1182/blood-2005-03-0975. Epub 2005 Aug 23.
5
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity.T细胞亲和力与调节:耐受性和自身免疫之间的灵活联系。
Int Rev Immunol. 2006 May-Aug;25(3-4):235-58. doi: 10.1080/08830180600743081.
6
Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.自身免疫耐受与1型(胰岛素依赖型)糖尿病
Diabetologia. 1992 Dec;35 Suppl 2:S49-59. doi: 10.1007/BF00586279.
7
CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells.CD4+ T细胞辅助选择性增强高亲和力肿瘤抗原特异性CD8+ T细胞。
J Immunol. 2015 Oct 1;195(7):3482-9. doi: 10.4049/jimmunol.1401571. Epub 2015 Aug 28.
8
High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.高抗原剂量和活化的树突状细胞可使辅助性T细胞在体外逃避调节性T细胞介导的抑制作用。
Eur J Immunol. 2003 Feb;33(2):502-11. doi: 10.1002/immu.200310026.
9
Medullary thymic epithelial cells and CD8α dendritic cells coordinately regulate central tolerance but CD8α cells are dispensable for thymic regulatory T cell production.髓质胸腺上皮细胞和CD8α树突状细胞协同调节中枢耐受,但CD8α细胞对于胸腺调节性T细胞的产生并非必需。
J Autoimmun. 2016 Dec;75:141-149. doi: 10.1016/j.jaut.2016.08.002. Epub 2016 Aug 16.
10
Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection.静息状态树突状细胞持续失活逃避胸腺阴性选择的 T 细胞。
Immunol Cell Biol. 2009 Nov-Dec;87(8):615-22. doi: 10.1038/icb.2009.46. Epub 2009 Jul 7.

引用本文的文献

1
Immunotherapy-induced acute interstitial nephritis with neutrophil infiltrate, looking like pyelonephritis.免疫疗法诱发的急性间质性肾炎伴中性粒细胞浸润,外观类似肾盂肾炎。
J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02332-3.
2
The diversity of CD8 T cell dysfunction in cancer and viral infection.癌症和病毒感染中CD8 T细胞功能障碍的多样性。
Nat Rev Immunol. 2025 Apr 11. doi: 10.1038/s41577-025-01161-6.
3
T cell dysfunction and therapeutic intervention in cancer.T 细胞功能障碍与癌症的治疗干预。
Nat Immunol. 2024 Aug;25(8):1344-1354. doi: 10.1038/s41590-024-01896-9. Epub 2024 Jul 18.
4
The Epidemiology of COVID-19 Vaccine-Induced Myocarditis.新型冠状病毒肺炎疫苗诱导的心肌炎的流行病学
Adv Med. 2024 Apr 18;2024:4470326. doi: 10.1155/2024/4470326. eCollection 2024.
5
Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy.活化的 B 细胞增强表位扩展以支持成功的癌症免疫治疗。
Front Immunol. 2024 Mar 19;15:1382236. doi: 10.3389/fimmu.2024.1382236. eCollection 2024.
6
Low-affinity CD8 T cells provide interclonal help to high-affinity CD8 T cells to augment alloimmunity.低亲和性 CD8 T 细胞为高亲和性 CD8 T 细胞提供了克隆间帮助,以增强同种异体免疫。
Am J Transplant. 2024 Jun;24(6):933-943. doi: 10.1016/j.ajt.2024.01.008. Epub 2024 Jan 14.
7
CAR-T treatment for cancer: prospects and challenges.嵌合抗原受体T细胞(CAR-T)疗法治疗癌症:前景与挑战。
Front Oncol. 2023 Dec 5;13:1288383. doi: 10.3389/fonc.2023.1288383. eCollection 2023.
8
Cell and biomaterial delivery strategies to induce immune tolerance.细胞和生物材料传递策略诱导免疫耐受。
Adv Drug Deliv Rev. 2023 Dec;203:115141. doi: 10.1016/j.addr.2023.115141. Epub 2023 Nov 18.
9
Reactivation of low avidity tumor-specific CD8 T cells associates with immunotherapeutic efficacy of anti-PD-1.低亲和度肿瘤特异性 CD8 T 细胞的再激活与抗 PD-1 的免疫治疗疗效相关。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007114.
10
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens.PD-1 维持 CD8 T 细胞对皮肤新生抗原的耐受。
Nature. 2023 Jul;619(7968):151-159. doi: 10.1038/s41586-023-06217-y. Epub 2023 Jun 21.

本文引用的文献

1
A central role for central tolerance.中枢耐受的核心作用。
Annu Rev Immunol. 2006;24:571-606. doi: 10.1146/annurev.immunol.23.021704.115601.
2
Autoimmunity and tumor immunity induced by immune responses to mutations in self.针对自身突变产生的免疫反应所诱导的自身免疫和肿瘤免疫。
Nat Med. 2006 Feb;12(2):198-206. doi: 10.1038/nm1363. Epub 2006 Jan 29.
3
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.散发性免疫原性肿瘤通过诱导T细胞耐受来避免被破坏。
Nature. 2005 Sep 1;437(7055):141-6. doi: 10.1038/nature03954.
4
The cellular mechanism of Aire control of T cell tolerance.Aire调控T细胞耐受性的细胞机制。
Immunity. 2005 Aug;23(2):227-39. doi: 10.1016/j.immuni.2005.07.005.
5
CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo.CD8α⁺树突状细胞在体内选择性呈递主要组织相容性复合体I类限制的非溶细胞性病毒和细胞内细菌抗原。
J Immunol. 2005 Jul 1;175(1):196-200. doi: 10.4049/jimmunol.175.1.196.
6
Genetic lesions in T-cell tolerance and thresholds for autoimmunity.T细胞耐受性中的基因损伤与自身免疫阈值
Immunol Rev. 2005 Apr;204:87-101. doi: 10.1111/j.0105-2896.2005.00253.x.
7
Peripheral tolerance of CD8 T lymphocytes.CD8 T淋巴细胞的外周耐受
Immunity. 2005 Mar;22(3):275-84. doi: 10.1016/j.immuni.2005.01.010.
8
Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation.由直接和间接抗原呈递介导的对组织特异性抗原的中枢耐受。
J Exp Med. 2004 Oct 18;200(8):1039-49. doi: 10.1084/jem.20041457.
9
Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity.基因剂量——Aire在胸腺表达、克隆清除及器官特异性自身免疫中的限制作用。
J Exp Med. 2004 Oct 18;200(8):1015-26. doi: 10.1084/jem.20040581.
10
TCR affinity and negative regulation limit autoimmunity.T细胞受体亲和力和负调控限制自身免疫。
Nat Med. 2004 Nov;10(11):1234-9. doi: 10.1038/nm1114. Epub 2004 Oct 3.